Robert Radie

Robert Radie

Net worth: 199 315 $ as of 30/08/2026

73 year
Health Technology
Commercial Services
Consumer Services

Profile

Robert Samuel Radie is Chairman & Chief Executive Officer at Neuraptive Therapeutics, Inc. since 2020.
He is Independent Chairman at Rockwell Medical, Inc. since 2022.
He serves as Director at Orcosa, Inc. starting in 2024 and Director at Valsource, Inc. since 2020.
Former roles include President & Chief Executive Officer at Topaz Pharmaceuticals, Inc. from 2010 to 2011, President & Chief Executive Officer at TransMolecular, Inc. from 2009 to 2010, Chief Executive Officer at Zyla Life Sciences US LLC from 2012 to 2019, Independent Director at Veloxis Pharmaceuticals A from 2016 to 2020, Director at Horse Power For Life from 2006 to 2024, Director at Egalet Ltd. from 2012 to 2020, Director at Affinium Pharmaceuticals Ltd. from 2013 to 2014, Independent Director at Paratek Pharmaceuticals, Inc. from 2014 to 2023, Chief Business Officer & Executive Vice President at Prestwick Pharmaceuticals, Inc. from 2007 to 2008, and Chief Financial Officer at Zyla Life Sciences LLC in 2019.
Other former positions include roles at Life Sciences Pennsylvania, Eli Lilly & Co., Vicuron Pharmaceuticals LLC, Morphotek, Inc. Education includes undergraduate studies at Boston College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
30/06/2026 23,985 ( 0.6% ) 199 315 $ 30/08/2026

Robert Radie active positions

CompaniesPositionStart
ROCKWELL MEDICAL, INC. Chairman 31/03/2022
Director/Board Member 15/11/2020
Chief Executive Officer 22/06/2020
Director/Board Member 31/12/2023

Former positions of Robert Radie

CompaniesPositionEnd
Director/Board Member 31/12/2023
PARATEK PHARMACEUTICALS, INC. Director/Board Member 20/09/2023
Chief Executive Officer -
VELOXIS PHARMACEUTICALS A/S Director/Board Member 31/01/2020
ZYLA LIFE SCIENCES Chief Executive Officer 21/10/2019
See the detail of Robert Radie's experience

Training of Robert Radie

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

59

1st degree connections

19

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies19

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!